Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
6.57
+0.03 (0.46%)
At close: Oct 30, 2025, 4:00 PM EDT
6.48
-0.09 (-1.37%)
After-hours: Oct 30, 2025, 4:46 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $51.25 million as of October 30, 2025. Its market cap has decreased by -77.94% in one year.
Market Cap
51.25M
Enterprise Value
103.75M
1-Year Change
-77.94%
Ranking
Category
Stock Price
$6.57
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $51.25M, a decrease of -84.76%. That is a compound annual growth rate of -31.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 51.01M | -77.08% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |